Patents by Inventor Florence Lambolez

Florence Lambolez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOSTIMULATORY MRNA COMPOSITIONS AND USES THEREOF
    Publication number: 20250041394
    Abstract: The invention is situated in the field of immunotherapy. More specifically, the invention is related to a composition of one or more nucleic acid molecule(s) encoding functional immunostimulatory proteins such as IL-21 and encoding a co-stimulatory molecule, optionally in combination with a cytokine, and/or a chemokine to enhance the host immune response against tumor cells present in the body. The invention further relates to nucleic acid containing compositions or pharmaceutical formulations for use in the treatment of patients suffering from a tumor and/or cancer disease.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 6, 2025
    Applicant: eTheRNA immunotherapies NV
    Inventors: Florence Lambolez, Elisabeth Brabants, Jessica Filtjens, Stefaan De Koker
  • Anti-TIGIT Antibodies
    Publication number: 20230190931
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: July 25, 2022
    Publication date: June 22, 2023
    Applicant: iTeos Belgium SA
    Inventors: Anthony COOPER, Christophe QUEVA, Sofie DENIES, Catherine HOOFD, Julia CUENDE, Gregory DRIESSENS, Florence LAMBOLEZ
  • Anti-TIGIT Antibodies
    Publication number: 20230181731
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 15, 2023
    Applicant: iTeos Belgium SA
    Inventors: Anthony COOPER, Christophe QUEVA, Sofie DENIES, Catherine HOOFD, Julia CUENDE, Gregory DRIESSENS, Florence LAMBOLEZ
  • Anti-TIGIT antibodies
    Patent number: 11439705
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: September 13, 2022
    Assignee: ITEOS BELGIUM SA
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20200407445
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: July 26, 2018
    Publication date: December 31, 2020
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20190315867
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: May 15, 2019
    Publication date: October 17, 2019
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • Anti-TIGIT antibodies
    Patent number: 10329349
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: June 25, 2019
    Assignee: iTeos Therapeutics SA
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens, Florence Lambolez
  • ANTI-TIGIT ANTIBODIES
    Publication number: 20190100591
    Abstract: Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 4, 2019
    Inventors: Anthony Cooper, Christophe Queva, Sofie Denies, Catherine Hoofd, Julie Cuende, Gregory Driessens, Florence Lambolez